In which patients with oncologic or hematologic disorders are you recommending a 3rd dose of mRNA COVID vaccine?

In the ideal world, we would tailor the need for booster shots based on whether or not a patient achieves an appropriate immunologic response and maintains that response for long periods of time. This would include both seroconversion and T-cell-mediated immunity. However, we have neither routine no...

As suggested by the recent CDC recommendations, an additional dose may be given to those with active treatment for solid tumor and malignancies, or those with stem cell transplant patients or CAR-T therapy. Our center has decided to follow the above general recommendations, but to let the primary he...